• 10 mM dNTP Mixture: Precision DNA Synthesis for Modern Workf

  2026-08-01

  The 10 mM dNTP (2'-deoxyribonucleoside-5'-triphosphate) Mixture from APExBIO delivers unmatched reproducibility and flexibility for PCR, DNA sequencing, and advanced DNA synthesis. Explore how this equimolar nucleotide mix streamlines workflows, supports high-fidelity results, and empowers innovative molecular biology research.

• TMEM16F Lipid Scrambling Regulates Ferroptosis and Tumor Imm

  2026-07-31

  Yang et al. uncover TMEM16F-mediated lipid scrambling as a key suppressor of ferroptosis, revealing that its inhibition not only sensitizes tumor cells to ferroptosis but also promotes tumor immune rejection. These findings advance our understanding of plasma membrane dynamics during cell death and highlight new avenues for combination cancer immunotherapy.

• Sodium Citrate in Programmable SERS Nanofabrication: Mechani

  2026-07-31

  Discover how sodium citrate empowers programmable SERS nanocluster arrays as a buffering agent, metal ion chelator, and protein stabilization reagent. This article delivers new insight into assay design and practical fabrication advances, building on the latest research and going beyond standard mechanistic reviews.

• 25-Hydroxycholesterol Drives Immunosuppressive Macrophage Re

  2026-07-30

  Xiao et al. uncover how 25-hydroxycholesterol (25HC) accumulates in tumor-associated macrophages (TAMs), activating AMPKα via a lysosomal pathway to promote an immunosuppressive phenotype. Their findings position CH25H-mediated metabolic rewiring as a key immunometabolic checkpoint, pointing to novel strategies for reshaping the tumor microenvironment and improving immunotherapy outcomes.

• LGK-974: Precision PORCN Inhibitor for Wnt Pathway Analysis

  2026-07-30

  LGK-974 uniquely enables nanomolar-precision modulation of the Wnt signaling pathway, driving breakthroughs in Wnt-driven cancer models with minimal off-target effects. Its reproducible performance in both in vitro and in vivo systems makes it the gold standard for preclinical studies targeting Wnt/β-catenin signaling.

• GKT137831: Reliable Dual Nox1/Nox4 Inhibitor for Oxidative S

  2026-07-29

  This article provides scenario-driven, evidence-based guidance for biomedical researchers and laboratory scientists working with GKT137831 (SKU B4763), a potent dual NADPH oxidase Nox1/Nox4 inhibitor. It addresses common workflow challenges in cell viability and oxidative stress assays and demonstrates how GKT137831 enhances reproducibility and interpretability, with practical protocol parameters and vendor selection advice.

• Glycogen Colorimetric Assay Kit II: High-Throughput Glycogen

  2026-07-29

  The Glycogen Colorimetric Assay Kit II streamlines high-throughput, interference-resistant quantification of glycogen in complex biological samples. By enabling precise measurements even in matrices with reducing substances, it empowers metabolic researchers to dissect glycogen dynamics across exercise, circadian, and disease contexts.

• Orthopoxvirus-Induced RIPK3 Degradation Modulates Inflammati

  2026-07-28

  Liu et al. (2021) reveal that orthopoxviruses encode a viral inducer of RIPK3 degradation (vIRD) which targets the necroptosis adaptor RIPK3 for SCF-mediated proteasomal degradation, thereby controlling virus-induced inflammation and replication. This discovery clarifies viral immune evasion strategies and highlights new targets for dissecting cell death pathways in infection and immunity.

• Spiroplasma eriocheiris Entry: Cytoskeletal Dependence in S2

  2026-07-28

  This study reveals that Spiroplasma eriocheiris invades Drosophila S2 cells via clathrin-mediated endocytosis and macropinocytosis, with a critical reliance on host microtubules and actin filaments. The findings clarify both the cellular entry mechanisms and the importance of cytoskeletal dynamics, informing future pathogen-host interaction research and cytoskeleton-targeted assays.

• Aurora Kinase A Overexpression in Retinoblastoma: Targeted T

  2026-07-27

  A recent study demonstrates that Aurora kinase A (AURKA) is significantly overexpressed in human retinoblastoma, correlating with high-risk histopathological features and poor chemotherapy response. These findings highlight the promise of AURKA as a targeted therapeutic avenue in advanced or refractory retinoblastoma, providing a foundation for the use of selective Aurora A inhibitors.

• Artesunate in Cancer Models: Protocol Insights & Innovations

  2026-07-27

  Artesunate, a semi-synthetic artemisinin derivative, is redefining in vitro cancer research through its dual action as a ferroptosis inducer and AKT/mTOR pathway inhibitor. This article unpacks optimized experimental workflows, practical troubleshooting, and strategic insights for deploying Artesunate in advanced oncology models, translating recent methodological breakthroughs into actionable guidance.

• Methylation and CNS Disorders: Insights from Ademetionine St

  2026-07-26

  This review synthesizes evidence on the clinical and biochemical significance of methylation, especially S-adenosylmethionine (SAMe), in neurological and psychiatric disorders. It details the role of methyl donor metabolism in CNS health and highlights potential avenues for therapeutic intervention.

• Live-Dead Bacterial Staining Kit: Viability Assay Innovation

  2026-07-25

  The Live-Dead Bacterial Staining Kit empowers researchers to precisely quantify bacterial viability in advanced infection and nanomaterial studies. By leveraging dual-dye fluorescence, this kit streamlines membrane integrity analysis and bridges translational gaps in microbiology research.

• AP-1 Inhibition Induces Ferroptosis in Myeloma via PI3K/AKT

  2026-07-24

  This study demonstrates that the C-Fos/AP-1 inhibitor T-5224 triggers ferroptosis in multiple myeloma cells by suppressing the PI3K/AKT pathway. These findings expand the understanding of T-5224’s mechanisms, highlighting its potential for combinatorial therapy and providing new insights into targeted cell death in hematological malignancy.

• Leucovorin Calcium: Advancing Methotrexate Rescue in Tumor M

  2026-07-24

  Leucovorin Calcium empowers researchers to precisely model methotrexate rescue and dissect antifolate drug resistance in complex assembloid systems. Its robust solubility and validated performance in patient-derived models make it indispensable for next-generation tumor–stroma interaction studies.

11909 records 1/794 page Next 12345 下5页 Last page